Adenocarcinoma of the Esophagus Completed Phase 1 / 2 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0030040 (Adenocarcinoma of the Esophagus)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01231399Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal CancerTreatment